共 169 条
[1]
Ewertz M(2015)Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives Acta Oncol 54 587-591
[2]
Qvortrup C(2005)Oxaliplatin-associated neuropathy: a review Ann Phamacother 39 128-135
[3]
Eckhoff L(2006)Oxaliplatin-related neurotoxicity. How and why? Crit Rev Oncol Hematol 59 159-168
[4]
Cersosimo RJ(2002)Oxaliplatin-related side effects: characteristics and management Semin Oncol 29 11-20
[5]
Pasetto LM(2002)Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures Semin Oncol 29 21-33
[6]
D'Andrea MR(2003)Oxaliplatin-safety profile: neurotoxicity Semin Oncol 30 5-13
[7]
Rossi E(2009)Survey of oxaliplatin-associated peripheral sensory neuropathy using an interview-based questionnaire in patients with advanced colorectal cancer Jpn J Cancer Chemother 36 1321-1325
[8]
Monfardini S(2007)Background noise: the experience of chemotherapy-induced peripheral neuropathy Nurs Res 56 323-331
[9]
Cassidy J(2014)Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review Support Care Cancer 22 2261-2269
[10]
Misset JL(1996)Chemotherapy-associated neurotoxicity: an important side effect-impacting on quality, rather than quantity, of life J Cancer Res Clin Oncol 122 511-512